{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:48:11Z","timestamp":1792079291177,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.10.021","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:25:39Z","timestamp":1792077939000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does Lower PTCy Dose Increase GVHD?"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-3245","authenticated-orcid":false,"given":"Nihar","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Bentolila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.10.021_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2026.08.003","article-title":"Reduced Cumulative Post-Transplant Cyclophosphamide Exposure is Associated with Increased Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation","author":"Soto","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"14","key":"10.1016\/j.jtct.2026.10.021_bib0002","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3390\/cancers16142567","article-title":"Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study","volume":"16","author":"Ju\u00e1rez","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jtct.2026.10.021_bib0003","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/bjh.70380","article-title":"Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia","volume":"208","author":"Desai","year":"2026","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.10.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2026.07.033","article-title":"Reduced-dose PTCy Plus Postengraftment Low-dose ATG for GVHD Prophylaxis in Haploidentical PBSC Transplantation","author":"An","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.10.021_bib0005","article-title":"Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A Systematic Review of Efficacy and Toxicity","author":"Shafqat","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.021_bib0006","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjh.19228","article-title":"Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation","volume":"204","author":"Fuji","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.10.021_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2026.102749","article-title":"Current role of ATG in GVHD prevention: optimizing post-transplantation outcomes through combination with PTCY","volume":"100","author":"Liga","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jtct.2026.10.021_bib0008","doi-asserted-by":"crossref","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 129(6):2357\u201373. doi:10.1172\/JCI124218 PubMed PMID: 30913039; PubMed Central PMCID: PMC6546453.","DOI":"10.1172\/JCI124218"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.021_bib0009","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.2016.148510","article-title":"Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Baron","year":"2017","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.021_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2026.05.004","article-title":"A Network Meta-Analysis of Randomized Trials to Determine Optimal GVHD Prophylaxis in Matched Sibling Donor Transplantation","volume":"32","author":"Bentolila","year":"2026","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726008109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726008109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:25:41Z","timestamp":1792077941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726008109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"alternative-id":["S2666636726008109"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.021","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Lower PTCy Dose Increase GVHD?","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}